{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:07:14Z","timestamp":1781820434742,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Special Fund of The Pediatric Medical Coordinated Development Center of Beijing Municipal Administration","award":["XTZD20180202"],"award-info":[{"award-number":["XTZD20180202"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81800189"],"award-info":[{"award-number":["81800189"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Municipal Administration of Hospitals\u2019 Youth Programme","award":["QML20181205"],"award-info":[{"award-number":["QML20181205"]}]},{"name":"Beijing Municipal Commission of Education","award":["KM201910025011"],"award-info":[{"award-number":["KM201910025011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Griscelli syndrome type 2 (GS2) is a rare autosomal recessive disease caused by mutations in<jats:italic>RAB27A<\/jats:italic>gene. It is primarily characterized by a combination of partial albinism, hemophagocytic lymphohistiocytosis (HLH) or other immunodeficiency. However, neurological involvement at onset in GS2 and treatment has rarely been described.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We describe a 3-year-old boy with GS2 in an Asian Chinese family. He presented with progressive neurological abnormalities following unremitting fever at onset. He developed HLH during the clinical course. A novel homozygous mutation (c.1\u00a0A\u2009&gt;\u2009G) in<jats:italic>RAB27A<\/jats:italic>gene was subsequently identified. He was then treated by HLH-1994 protocol combined with ruxolitinib and experienced a dramatic remission. He subsequently underwent a successful haploidentical hematopoietic stem cell transplantation and stayed at a good condition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We reported an atypical form of GS2 manifesting as severe central nervous system involvement at onset and subsequent HLH, which was successfully rescued in time. This case also highlights the need for early consideration of immunologic and genetic evaluation for HLH in unexplained neuroinflammation in the diagnostic work up.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12887-021-02720-1","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T12:05:26Z","timestamp":1622462726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Successful rescue of a lethal Griscelli syndrome type 2 presenting with neurological involvement and hemophagocytic lymphohistiocytosis: a case report"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0404-5743","authenticated-orcid":false,"given":"Qing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ze","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Hao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,31]]},"reference":[{"issue":"16","key":"2720_CR1","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1182\/blood.2019000936","volume":"135","author":"W Scott","year":"2020","unstructured":"Scott W, Canna, Rebecca A, Marsh. Pediatric hemophagocytic lymphohistiocytosis. Blood. 2020;135(16):1332\u201343.","journal-title":"Blood"},{"issue":"11","key":"2720_CR2","doi-asserted-by":"publisher","first-page":"e27929","DOI":"10.1002\/pbc.27929","volume":"66","author":"MB Jordan","year":"2019","unstructured":"Jordan MB, Allen CE, Greenberg J, Henry M, Hermiston ML, Kumar A, et al. Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatr Blood Cancer. 2019;66(11):e27929.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2720_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/ng0797-289","volume":"16","author":"E Pastural","year":"1997","unstructured":"Pastural E, Barrat FJ, Dufourcq-Lagelouse R, Certain S, Sanal O, Jabado N, et al. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat Genet. 1997;16(3):289\u201392.","journal-title":"Nat Genet"},{"issue":"3","key":"2720_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1172\/JCI200318264","volume":"112","author":"G Menasche","year":"2003","unstructured":"Menasche G, Ho CH, Sanal O, J\u00e9r\u00f4me Feldmann I, Tezcan F, Ersoy, et al. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J Clin Invest. 2003;112(3):450\u20136.","journal-title":"J Clin Invest"},{"issue":"2","key":"2720_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/76024","volume":"25","author":"G Menasche","year":"2000","unstructured":"Menasche G, Pastural E, Feldmann J, Ersoy F, Dupuis S, Wulffraat N, et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet. 2000;25(2):173\u20136.","journal-title":"Nat Genet"},{"issue":"6","key":"2720_CR6","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.4049\/jimmunol.1501284","volume":"196","author":"M Zhang","year":"2016","unstructured":"Zhang M, Bracaglia C, Prencipe G, Christina J, Bemrich-Stolz T, Beukelman, Reed A, Dimmitt, et al. A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis. J Immunol. 2016;196(6):2492\u2013503.","journal-title":"J Immunol"},{"key":"2720_CR7","doi-asserted-by":"crossref","unstructured":"Marie Meeths, Yenan T, Bryceson E, Rudd C, Zheng SM, Wood K. Ramme, et al. Clinical presentation of Griscelli syndrome type 2 and spectrum of RAB27A mutations. Pediatr Blood Cancer. 2010;54(4):563\u201372.","DOI":"10.1002\/pbc.22357"},{"issue":"1","key":"2720_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jb\/mvi002","volume":"137","author":"M Fukuda","year":"2005","unstructured":"Fukuda M. Versatile role of Rab27 in membrane trafficking: focus on the Rab27 effector families. J Biochem. 2005;137(1):9\u201316.","journal-title":"J Biochem"},{"issue":"13","key":"2720_CR9","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1182\/blood-2015-12-684399","volume":"127","author":"R Das","year":"2016","unstructured":"Das R, Guan P, Sprague L, Verbist K, Tedrick P, An QA, et al. Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis. Blood. 2016;127(13):1666\u201375.","journal-title":"Blood"},{"issue":"1","key":"2720_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1182\/blood-2016-02-700013","volume":"128","author":"FE Sophia Maschalidi","year":"2016","unstructured":"Sophia Maschalidi FE, Sepulveda A, Garrigue A, Fischer. Genevi\u00e8ve de Saint Basile. Therapeutic effect of JAK1\/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice. Blood. 2016;128(1):60\u201371.","journal-title":"Blood"},{"issue":"2","key":"2720_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1182\/blood.2019000761","volume":"134","author":"C Sabrin Albeituni, Katherine","year":"2019","unstructured":"Sabrin Albeituni, Katherine C, Verbist PE, Tedrick H, Tillman J, Picarsic R, Bassett, et al. Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis. Blood. 2019;134(2):147\u201359.","journal-title":"Blood"},{"key":"2720_CR12","doi-asserted-by":"crossref","unstructured":"Zhao Y, Shi J, Li X, Wang J, Sun J. Jianfeng Zhou, et al. Salvage therapy with dose-escalating ruxolitinib as a bridge to allogeneic stem cell transplantation for refractory hemophagocytic lymphohistiocytosis. Bone Marrow Transplant. 2020;55(4):824\u20136.","DOI":"10.1038\/s41409-019-0577-2"},{"issue":"12","key":"2720_CR13","doi-asserted-by":"publisher","first-page":"e630","DOI":"10.1016\/S2352-3026(19)30156-5","volume":"6","author":"SA Asra Ahmed","year":"2019","unstructured":"Asra Ahmed SA, Merrill F, Alsawah P, Bockenstedt E, Campagnaro S, Devata, et al. Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. Lancet Haematol. 2019;6(12):e630\u20137.","journal-title":"Lancet Haematol"},{"issue":"5","key":"2720_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.pediatrneurol.2015.01.010","volume":"52","author":"R Inusha Panigrahi","year":"2015","unstructured":"Inusha Panigrahi R, Suthar A, Rawat B, Behera. Seizure as the presenting manifestation in Griscelli syndrome type 2. Pediatr Neurol. 2015;52(5):535\u20138.","journal-title":"Pediatr Neurol"},{"issue":"8","key":"2720_CR15","doi-asserted-by":"crossref","first-page":"e28312","DOI":"10.1002\/pbc.28312","volume":"67","author":"E Kristine","year":"2020","unstructured":"Kristine E, Woodward RM, Shah S, Benseler X-C, Wei D, Ng J, Grossman, et al. Considering immunologic and genetic evaluation for HLH in neuroinflammation: A case of Griscelli syndrome type 2 with neurological symptoms and a lack of albinism. Pediatr Blood Cancer. 2020;67(8):e28312.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2720_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3345\/kjp.2014.57.2.91","volume":"57","author":"S Kirtisudha Mishra","year":"2014","unstructured":"Kirtisudha Mishra S, Singla S, Sharma R, Saxena. Vineeta Vijay Batra. Griscelli syndrome type 2: a novel mutation in RAB27A gene with different clinical features in 2 siblings: a diagnostic conundrum. Korean J Pediatr. 2014;57(2):91\u20135.","journal-title":"Korean J Pediatr"},{"issue":"3","key":"2720_CR17","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/pbc.22239","volume":"54","author":"L Shuang Yang","year":"2010","unstructured":"Shuang Yang L, Zhang C, Jia H, Ma J-I, Henter K, Shen. Frequency and development of CNS involvement in Chinese children with hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2010;54(3):408\u201315.","journal-title":"Pediatr Blood Cancer"},{"issue":"15","key":"2720_CR18","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.4103\/0366-6999.237409","volume":"131","author":"Y-Z Zhao","year":"2018","unstructured":"Zhao Y-Z, Zhang Q, Li Z-G, Zhang L, Lian H-Y, Ma H-H, et al. Central Nervous System Involvement in 179 Chinese Children with Hemophagocytic Lymphohistiocytosis. Chin Med J (Engl). 2018;131(15):1786\u201392.","journal-title":"Chin Med J (Engl)"},{"issue":"6","key":"2720_CR19","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10875-020-00814-6","volume":"40","author":"M Annaliesse Blincoe","year":"2020","unstructured":"Annaliesse Blincoe M, Heeg PK, Campbell M, Hines A, Khojah M, Klein-Gitelman, et al. Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis. J Clin Immunol. 2020;40(6):901\u201316.","journal-title":"J Clin Immunol"},{"issue":"10","key":"2720_CR20","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1038\/s41409-020-0885-6","volume":"55","author":"M Al-Mofareh","year":"2020","unstructured":"Al-Mofareh M, Ayas M, Al-Seraihy A, Siddiqui K, Al-Jefri A, Ghemlas I, et al. Hematopoietic stem cell transplantation in children with Griscelli syndrome type 2: a single-center report on 35 patients. Bone Marrow Transplant. 2020;55(10):2026\u201334.","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2720_CR21","first-page":"1310-8.e1","volume":"135","author":"Y Valentina Cetica","year":"2015","unstructured":"Valentina Cetica Y, Hackmann S, Grieve E, Sieni B, Ciambotti ML, Coniglio, et al. Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding. J Allergy Clin Immunol. 2015;135(5):1310-8.e1.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2720_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jaci.2018.02.031","volume":"142","author":"J Bianca Tesi","year":"2018","unstructured":"Bianca Tesi J, Rascon, Samuel CC, Chiang B, Burnyte A, L\u00f6fstedt A, Fasth, et al. A RAB27A 5\u2019 untranslated region structural variant associated with late-onset hemophagocytic lymphohistiocytosis and normal pigmentation. J Allergy Clin Immunol. 2018;142(1):317\u201321.e8.","journal-title":"J Allergy Clin Immunol"},{"key":"2720_CR23","doi-asserted-by":"publisher","first-page":"612977","DOI":"10.3389\/fimmu.2020.612977","volume":"11","author":"S Yuta Ohishi","year":"2020","unstructured":"Yuta Ohishi S, Ammann V, Ziaee K, Strege M, Gro\u00df CV, Amos, et al. Griscelli Syndrome Type 2 Sine Albinism: Unraveling Differential RAB27A Effector Engagement. Front Immunol. 2020;11:612977.","journal-title":"Front Immunol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02720-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-021-02720-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02720-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T10:05:43Z","timestamp":1699092343000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-021-02720-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,31]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2720"],"URL":"https:\/\/doi.org\/10.1186\/s12887-021-02720-1","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,31]]},"assertion":[{"value":"21 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study wasconducted in accordance with the Declaration of Helsinki and approved by theEthics Committee at Beijing children\u2019s Hospital, Capital Medical University.The patient\u2019s parent signed an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This patient wasunder 16\u2009years old, and his parent signed an informed consent form forpublication. A copy of the written consent is available for review by theEditor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"253"}}